Numais Co., Ltd. pursues to build fundamental knowledge and to establish the state-of-the-art synthesis methodologies on the stem-cell derived nanovesicle theragnostics and the thermo-sensitive biodegradable hydrogel delivery systems, thereby maximizing the efficacy of the stem-cell therapeutics and the predictability of drug delivery systems.
We ultimately aim to improve the quality of life for patients suffering from various types of inflammatory diseases.